Leerink Swann on DUSA Pharmaceuticals (DUSA): An Unusual Small Cap Opportunity; Steady, Profitable Growth in a Large Market
Go back to Leerink Swann on DUSA Pharmaceuticals (DUSA): An Unusual Small Cap Opportunity; Steady, Profitable Growth in a Large Market| Dusa Pharmaceuticals, Inc. (NYSE: DUSA) | Delayed: 57.59 +0.47 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.12 | 52 Week High | $8.01 | |||
| Open | $57.52 | 52 Week Low | $4.10 | |||
| Day High | $57.72 | P/E | 479.92 | |||
| Day Low | $57.50 | EPS | $0.12 | |||
| Volume | 9,614 | |||||
